Tags |
|
|
Links |
|
|
Wiki Articles - Trade Exits and Opportunity Costs
There are many approaches to initiating trades and selecting stocks for investment purposes, but many of the "experts" who provide advice on getting int
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
o a day trading or investment position fall short when it comes to insights into when and at what price to get out. Let's assume for purposes of this di
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
scussion that you have a rational basis for making the investment, or initiating the trade, in the first place, and that you have a reasonably well-disc
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
iplined approach to cutting your losses if the price of the stock does the opposite of what you expect or hope. Often the situation that experienced tra
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ders, and especially long-term investors, have the most difficulty dealing with is the happy period when the price of the stock has risen well into the
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
profit range. How do you know when and where to get out?
A brief description of the economic concept of "opportunity cost" can help us bring some logic
A brief description of the economic concept of "opportunity cost" can help us bring some logic
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
and good judgement to the challenge of deciding when to exit trades. Opportunity cost is the value of the next best thing you can do with your resource
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
s. Your resources clearly include your money, but they can also include your time and your comfort. For example, let’s say you bought a ticket to a show
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
or game that you really look forward to seeing, and when you arrive for the big event you discover that fans are offering to buy tickets from scalpers
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
for ten times the price you paid.
Now, you might think that your cost of attending the event is simply the price you originally paid for the ticket. Bu
Now, you might think that your cost of attending the event is simply the price you originally paid for the ticket. Bu
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
t, in economic terms, your cost is equal to the value of your second highest priority choice about what to do with both the time you have allocated to t
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
he event for which you hold a ticket, and the amount of money you could get by selling your ticket at the new, higher free-market price. Your “opportuni
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ty cost” for using your ticket to see the event rather than converting your ticket to cash is equal to the price you could get for your ticket rather th
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
an the price you paid for your ticket.
How does this apply to exiting a trade or an investment? It is actually quite simple. As your profit in a given
How does this apply to exiting a trade or an investment? It is actually quite simple. As your profit in a given
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
stock or investment increases, at regular points in time based on the time horizon of your trade or investment, you should ask yourself if you would buy
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
the asset you currently own at the current price as a new investment or trade. If the answer is “yes” then keep holding, but if the answer is “no” then
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
it is time to convert to cash and take advantage of that second highest priority trade or investment that is waiting for your time, attention and capit
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
al. Whether you are day trading or investing for longer periods, it is often best to take the easy, early profit from a trade and then convert to cash s
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
o you can objectively evaluate the other opportunities available to you.
Of course, you should never let the temptation to take profits early interfere
Of course, you should never let the temptation to take profits early interfere
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
with your ability to maintain disciplined management of your trading system or investment plan. Patience is the key to profitably managing any system.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.wiki-articles.org.ua/article/102894/wiki-articles-Trade-Exits-and-Opportunity-Costs.html">Trade Exits and Opportunity Costs</a>
BB link (for phorums):
[url=http://www.wiki-articles.org.ua/article/102894/wiki-articles-Trade-Exits-and-Opportunity-Costs.html]Trade Exits and Opportunity Costs[/url]
Related Articles:
How to Get Employers to Call You for a Job Interview?
How To Bankrupt Your Student Loans
Bookmark it:
|